Novartis
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Novartis was mentioned 36 times in 15 outlets across 5 countries over the last 12 months. 31% of that coverage was positive and 3% negative.
MENTIONS · 12M
36
38 all-time
OUTLETS · 12M
15
in 5 countries
AVG SENTIMENT
+0.190
Recent coverage
Novartis India Ltd. Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
valueresearchonline.com · IN · 31 Aug 2026 · neutral
Novartis stock trades below consensus target as post-earnings digestion continues - ad-hoc-news.de
ad-hoc-news.de · DE · 31 Aug 2026 · neutral
Novartis Selects Winter Park for New Radioligand Therapy Manufacturing Facility - Orlando Economic Partnership
news.orlando.org · INT · 24 Aug 2026 · positive
Novartis plans $280M facility in Denton to produce ‘next-generation’ cancer treatments - Denton Record-Chronicle
dentonrc.com · INT · 20 Aug 2026 · positive
Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent - Yahoo Finance
finance.yahoo.com · INT · 13 Aug 2026 · positive
Novartis - Wikipedia
en.wikipedia.org · INT · 10 Aug 2026 · neutral
Inside Q2’s digital banking funding boom
cbinsights.com · MY · 6 Aug 2026 · neutral
Q2 growth for Novartis as new drugs offset patent cliff - EMJ
emjreviews.com · INT · 21 Jul 2026 · neutral
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 1 |
| 2026-01 | 0 |
| 2026-02 | 1 |
| 2026-03 | 0 |
| 2026-04 | 1 |
| 2026-05 | 5 |
| 2026-06 | 19 |
| 2026-07 | 2 |
| 2026-08 | 7 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Novartis against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page